 Thomas Jansson
Concepts (417)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta | 79 | 2023 | 628 | 16.920 |
Why?
| | Fetal Growth Retardation | 36 | 2023 | 470 | 8.570 |
Why?
| | Trophoblasts | 38 | 2023 | 165 | 8.310 |
Why?
| | TOR Serine-Threonine Kinases | 42 | 2023 | 359 | 7.370 |
Why?
| | Fetal Development | 29 | 2023 | 248 | 6.890 |
Why?
| | Pregnancy | 115 | 2023 | 5499 | 5.160 |
Why?
| | Maternal-Fetal Exchange | 22 | 2021 | 151 | 5.010 |
Why?
| | Amino Acid Transport System A | 11 | 2021 | 33 | 4.520 |
Why?
| | Diabetes, Gestational | 16 | 2023 | 281 | 4.500 |
Why?
| | Amino Acids | 21 | 2023 | 445 | 4.230 |
Why?
| | Adiponectin | 13 | 2022 | 213 | 4.040 |
Why?
| | Pregnancy Complications | 14 | 2020 | 430 | 3.710 |
Why?
| | Insulin-Like Growth Factor Binding Protein 1 | 16 | 2023 | 24 | 3.650 |
Why?
| | Insulin | 28 | 2023 | 2080 | 3.220 |
Why?
| | Insulin-Like Growth Factor I | 16 | 2023 | 286 | 2.960 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 14 | 2023 | 97 | 2.930 |
Why?
| | Glucose Intolerance | 5 | 2022 | 137 | 2.830 |
Why?
| | Maternal Nutritional Physiological Phenomena | 11 | 2021 | 141 | 2.760 |
Why?
| | Obesity | 21 | 2023 | 2505 | 2.730 |
Why?
| | Amino Acid Transport Systems | 13 | 2020 | 38 | 2.620 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 9 | 2023 | 55 | 2.520 |
Why?
| | Folic Acid | 7 | 2021 | 161 | 2.330 |
Why?
| | Signal Transduction | 38 | 2023 | 4501 | 2.320 |
Why?
| | Fetal Macrosomia | 10 | 2023 | 58 | 2.240 |
Why?
| | Birth Weight | 13 | 2021 | 439 | 2.120 |
Why?
| | Papio | 14 | 2021 | 96 | 2.060 |
Why?
| | Pregnancy Proteins | 6 | 2022 | 36 | 1.980 |
Why?
| | Amino Acid Transport System L | 5 | 2021 | 16 | 1.960 |
Why?
| | Prenatal Exposure Delayed Effects | 7 | 2022 | 453 | 1.900 |
Why?
| | Fetus | 15 | 2021 | 698 | 1.870 |
Why?
| | Female | 120 | 2023 | 59324 | 1.830 |
Why?
| | Placental Insufficiency | 5 | 2019 | 102 | 1.830 |
Why?
| | Folate Receptor 1 | 4 | 2019 | 13 | 1.680 |
Why?
| | Decidua | 7 | 2022 | 23 | 1.640 |
Why?
| | Cell Membrane | 11 | 2020 | 670 | 1.610 |
Why?
| | Fetal Weight | 7 | 2021 | 52 | 1.590 |
Why?
| | Placentation | 6 | 2021 | 40 | 1.540 |
Why?
| | Insulin Resistance | 9 | 2022 | 1072 | 1.530 |
Why?
| | Multiprotein Complexes | 6 | 2015 | 140 | 1.510 |
Why?
| | Biological Transport | 16 | 2021 | 374 | 1.500 |
Why?
| | Extracellular Vesicles | 2 | 2022 | 83 | 1.380 |
Why?
| | Glucose Transporter Type 1 | 5 | 2020 | 43 | 1.380 |
Why?
| | Down-Regulation | 8 | 2020 | 594 | 1.310 |
Why?
| | Animals | 57 | 2023 | 31565 | 1.300 |
Why?
| | Folic Acid Deficiency | 3 | 2021 | 48 | 1.290 |
Why?
| | Fetal Nutrition Disorders | 3 | 2015 | 7 | 1.230 |
Why?
| | Phosphorylation | 23 | 2023 | 1558 | 1.210 |
Why?
| | Blood Glucose | 7 | 2023 | 1827 | 1.210 |
Why?
| | Heart Diseases | 2 | 2022 | 329 | 1.130 |
Why?
| | Fatty Liver | 2 | 2022 | 209 | 1.120 |
Why?
| | Diet, Protein-Restricted | 2 | 2021 | 10 | 1.040 |
Why?
| | Pregnancy Trimester, First | 6 | 2021 | 125 | 1.020 |
Why?
| | Leucine | 7 | 2021 | 102 | 1.000 |
Why?
| | Gestational Age | 14 | 2021 | 761 | 1.000 |
Why?
| | Humans | 95 | 2023 | 114045 | 0.980 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2021 | 801 | 0.980 |
Why?
| | Adiposity | 4 | 2023 | 458 | 0.920 |
Why?
| | Cells, Cultured | 21 | 2021 | 3861 | 0.910 |
Why?
| | Symporters | 1 | 2023 | 52 | 0.880 |
Why?
| | Reduced Folate Carrier Protein | 3 | 2019 | 8 | 0.870 |
Why?
| | Pregnancy, Animal | 3 | 2014 | 52 | 0.850 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 2 | 2021 | 9 | 0.840 |
Why?
| | Caloric Restriction | 2 | 2015 | 89 | 0.840 |
Why?
| | Body Mass Index | 12 | 2021 | 1957 | 0.830 |
Why?
| | Intracellular Signaling Peptides and Proteins | 5 | 2023 | 388 | 0.830 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2023 | 122 | 0.810 |
Why?
| | Overnutrition | 1 | 2022 | 30 | 0.770 |
Why?
| | Liver | 6 | 2023 | 1633 | 0.760 |
Why?
| | Glucose Transport Proteins, Facilitative | 2 | 2014 | 7 | 0.760 |
Why?
| | Infant, Newborn | 19 | 2023 | 5038 | 0.760 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 3 | 2021 | 249 | 0.730 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 18 | 0.730 |
Why?
| | Overweight | 3 | 2017 | 473 | 0.730 |
Why?
| | Lipid Metabolism | 6 | 2023 | 441 | 0.730 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 40 | 0.720 |
Why?
| | Pregnancy Trimester, Second | 2 | 2020 | 66 | 0.720 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2020 | 22 | 0.720 |
Why?
| | Serotonin | 2 | 2020 | 292 | 0.710 |
Why?
| | Membrane Transport Proteins | 3 | 2023 | 138 | 0.710 |
Why?
| | Fatty Acid Transport Proteins | 4 | 2018 | 18 | 0.710 |
Why?
| | Leptin | 4 | 2015 | 210 | 0.690 |
Why?
| | Mice | 16 | 2023 | 14843 | 0.690 |
Why?
| | Food Deprivation | 3 | 2020 | 24 | 0.690 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2020 | 24 | 0.680 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2020 | 55 | 0.660 |
Why?
| | Glucose | 10 | 2022 | 899 | 0.640 |
Why?
| | Adult | 36 | 2023 | 30375 | 0.640 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 2 | 2015 | 34 | 0.630 |
Why?
| | Infant, Premature | 2 | 2022 | 478 | 0.610 |
Why?
| | Adaptor Proteins, Signal Transducing | 5 | 2015 | 367 | 0.610 |
Why?
| | Protein Kinases | 4 | 2019 | 304 | 0.610 |
Why?
| | Fatty Acid-Binding Proteins | 4 | 2018 | 60 | 0.600 |
Why?
| | PPAR gamma | 5 | 2022 | 182 | 0.600 |
Why?
| | Regulatory-Associated Protein of mTOR | 6 | 2019 | 17 | 0.590 |
Why?
| | Fusion Regulatory Protein 1, Light Chains | 2 | 2015 | 6 | 0.590 |
Why?
| | Mice, Inbred C57BL | 10 | 2020 | 4680 | 0.580 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2015 | 139 | 0.580 |
Why?
| | Metabolic Diseases | 1 | 2018 | 98 | 0.570 |
Why?
| | Specimen Handling | 1 | 2018 | 153 | 0.570 |
Why?
| | Mice, Obese | 4 | 2022 | 53 | 0.570 |
Why?
| | Fatty Acids, Unsaturated | 4 | 2018 | 84 | 0.570 |
Why?
| | Casein Kinase II | 7 | 2021 | 21 | 0.570 |
Why?
| | Disease Models, Animal | 9 | 2022 | 3498 | 0.560 |
Why?
| | Organ Size | 8 | 2021 | 434 | 0.560 |
Why?
| | RNA Interference | 5 | 2021 | 431 | 0.560 |
Why?
| | Transcriptome | 3 | 2022 | 723 | 0.550 |
Why?
| | Homeostasis | 1 | 2020 | 570 | 0.530 |
Why?
| | AMP-Activated Protein Kinases | 5 | 2022 | 170 | 0.520 |
Why?
| | Hormones | 2 | 2008 | 132 | 0.510 |
Why?
| | Chorionic Villi | 4 | 2019 | 16 | 0.510 |
Why?
| | Altitude | 1 | 2019 | 435 | 0.510 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 5 | 2015 | 57 | 0.490 |
Why?
| | Docosahexaenoic Acids | 4 | 2023 | 69 | 0.480 |
Why?
| | Proteome | 1 | 2018 | 337 | 0.480 |
Why?
| | RNA, Small Interfering | 6 | 2023 | 534 | 0.480 |
Why?
| | Weight Gain | 2 | 2015 | 453 | 0.470 |
Why?
| | Rapamycin-Insensitive Companion of mTOR Protein | 5 | 2019 | 28 | 0.460 |
Why?
| | Homocysteine | 2 | 2017 | 137 | 0.450 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2013 | 24 | 0.440 |
Why?
| | Ubiquitination | 3 | 2022 | 86 | 0.440 |
Why?
| | Vitamin D | 1 | 2016 | 340 | 0.430 |
Why?
| | Nutritional Status | 1 | 2015 | 286 | 0.430 |
Why?
| | Diet, High-Fat | 4 | 2022 | 225 | 0.430 |
Why?
| | Gene Expression Regulation | 5 | 2021 | 2322 | 0.420 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 1726 | 0.410 |
Why?
| | Primary Cell Culture | 6 | 2019 | 148 | 0.410 |
Why?
| | Fatty Acids | 5 | 2022 | 380 | 0.410 |
Why?
| | Proton-Coupled Folate Transporter | 3 | 2019 | 8 | 0.410 |
Why?
| | Pregnancy in Diabetics | 3 | 2021 | 82 | 0.400 |
Why?
| | Placental Circulation | 6 | 2019 | 56 | 0.400 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2022 | 397 | 0.390 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 3 | 2016 | 13 | 0.390 |
Why?
| | Male | 22 | 2023 | 55396 | 0.380 |
Why?
| | Case-Control Studies | 5 | 2021 | 3003 | 0.380 |
Why?
| | Microvilli | 4 | 2019 | 70 | 0.370 |
Why?
| | PPAR alpha | 4 | 2015 | 52 | 0.360 |
Why?
| | Cohort Studies | 6 | 2023 | 4883 | 0.360 |
Why?
| | STAT3 Transcription Factor | 2 | 2014 | 172 | 0.350 |
Why?
| | Biological Availability | 2 | 2023 | 119 | 0.350 |
Why?
| | Hypoxia | 3 | 2022 | 956 | 0.340 |
Why?
| | Oleic Acid | 3 | 2014 | 30 | 0.340 |
Why?
| | Dietary Proteins | 1 | 2011 | 121 | 0.340 |
Why?
| | Dietary Fats | 2 | 2008 | 287 | 0.330 |
Why?
| | Carrier Proteins | 5 | 2021 | 694 | 0.330 |
Why?
| | Ion Transport | 1 | 2009 | 54 | 0.330 |
Why?
| | Rats, Wistar | 8 | 2021 | 368 | 0.320 |
Why?
| | Rats | 10 | 2021 | 4913 | 0.320 |
Why?
| | Fetal Blood | 3 | 2023 | 268 | 0.320 |
Why?
| | beta-Alanine | 2 | 2006 | 17 | 0.310 |
Why?
| | Proteolysis | 2 | 2022 | 142 | 0.310 |
Why?
| | Receptors, Adiponectin | 3 | 2019 | 15 | 0.310 |
Why?
| | In Vitro Techniques | 5 | 2021 | 1003 | 0.310 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 2 | 2023 | 15 | 0.290 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2020 | 92 | 0.290 |
Why?
| | Food | 1 | 2009 | 160 | 0.280 |
Why?
| | Amino Acid Transport Systems, Neutral | 1 | 2007 | 3 | 0.280 |
Why?
| | Malaria, Falciparum | 2 | 2017 | 25 | 0.280 |
Why?
| | RNA, Messenger | 5 | 2023 | 2550 | 0.280 |
Why?
| | Hyperglycemia | 2 | 2007 | 292 | 0.270 |
Why?
| | Hypoglycemic Agents | 3 | 2019 | 1011 | 0.270 |
Why?
| | Protein Transport | 3 | 2021 | 391 | 0.270 |
Why?
| | Taurine | 1 | 2007 | 41 | 0.270 |
Why?
| | Up-Regulation | 3 | 2015 | 802 | 0.260 |
Why?
| | DNA Methylation | 2 | 2023 | 493 | 0.260 |
Why?
| | Biological Transport, Active | 3 | 2015 | 71 | 0.260 |
Why?
| | Cesarean Section | 2 | 2022 | 169 | 0.260 |
Why?
| | CD36 Antigens | 2 | 2016 | 36 | 0.260 |
Why?
| | Hep G2 Cells | 7 | 2021 | 59 | 0.250 |
Why?
| | Energy Intake | 1 | 2008 | 427 | 0.250 |
Why?
| | Gene Knockdown Techniques | 3 | 2021 | 301 | 0.250 |
Why?
| | Chromatography, Liquid | 2 | 2023 | 345 | 0.240 |
Why?
| | Palmitic Acid | 2 | 2014 | 37 | 0.240 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2004 | 45 | 0.240 |
Why?
| | Cell Hypoxia | 3 | 2021 | 221 | 0.240 |
Why?
| | Young Adult | 8 | 2021 | 10444 | 0.230 |
Why?
| | Tandem Mass Spectrometry | 2 | 2023 | 410 | 0.230 |
Why?
| | Protein Kinase C-alpha | 2 | 2021 | 41 | 0.230 |
Why?
| | Phospholipids | 2 | 2023 | 194 | 0.230 |
Why?
| | Gene Silencing | 4 | 2021 | 171 | 0.230 |
Why?
| | Maternal Age | 3 | 2021 | 116 | 0.230 |
Why?
| | Amino Acids, Essential | 1 | 2023 | 12 | 0.220 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2022 | 130 | 0.220 |
Why?
| | Term Birth | 2 | 2015 | 19 | 0.220 |
Why?
| | Umbilical Veins | 2 | 2014 | 57 | 0.210 |
Why?
| | Embryonic Development | 2 | 2021 | 117 | 0.210 |
Why?
| | Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 14 | 0.200 |
Why?
| | Adult Children | 1 | 2022 | 21 | 0.200 |
Why?
| | Body Weight | 3 | 2012 | 868 | 0.200 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2023 | 100 | 0.200 |
Why?
| | Fetal Heart | 1 | 2022 | 37 | 0.200 |
Why?
| | Sirolimus | 5 | 2020 | 181 | 0.200 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 31 | 0.200 |
Why?
| | Carnitine | 1 | 2022 | 62 | 0.200 |
Why?
| | Animals, Newborn | 2 | 2018 | 777 | 0.190 |
Why?
| | Inflammation Mediators | 2 | 2015 | 475 | 0.190 |
Why?
| | Glucose Tolerance Test | 1 | 2022 | 343 | 0.190 |
Why?
| | Intra-Abdominal Fat | 1 | 2022 | 77 | 0.190 |
Why?
| | Testosterone | 2 | 2016 | 341 | 0.180 |
Why?
| | Cardiomegaly | 1 | 2022 | 158 | 0.180 |
Why?
| | Infant, Low Birth Weight | 2 | 2019 | 124 | 0.180 |
Why?
| | Triglycerides | 4 | 2023 | 467 | 0.180 |
Why?
| | Monoamine Oxidase | 1 | 2020 | 27 | 0.180 |
Why?
| | Organogenesis | 1 | 2021 | 55 | 0.180 |
Why?
| | Umbilical Cord | 1 | 2020 | 80 | 0.180 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 328 | 0.180 |
Why?
| | Cell Culture Techniques | 2 | 2021 | 341 | 0.170 |
Why?
| | Embryo, Mammalian | 1 | 2021 | 213 | 0.170 |
Why?
| | Adipocytes | 1 | 2022 | 188 | 0.170 |
Why?
| | Skinfold Thickness | 1 | 2020 | 49 | 0.170 |
Why?
| | Biomarkers | 3 | 2022 | 3397 | 0.170 |
Why?
| | Infant | 3 | 2023 | 7943 | 0.170 |
Why?
| | Myometrium | 1 | 2019 | 35 | 0.160 |
Why?
| | Immunohistochemistry | 3 | 2018 | 1624 | 0.160 |
Why?
| | Organelle Biogenesis | 1 | 2019 | 14 | 0.160 |
Why?
| | Enzyme Activation | 3 | 2015 | 771 | 0.160 |
Why?
| | Child, Preschool | 3 | 2023 | 9114 | 0.160 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2019 | 47 | 0.160 |
Why?
| | Lysophosphatidylcholines | 1 | 2018 | 20 | 0.160 |
Why?
| | Myoblasts, Skeletal | 1 | 2018 | 11 | 0.160 |
Why?
| | Protein Kinase C | 2 | 2021 | 271 | 0.160 |
Why?
| | Olive Oil | 1 | 2018 | 3 | 0.160 |
Why?
| | Models, Biological | 4 | 2021 | 1611 | 0.160 |
Why?
| | Electron Transport | 1 | 2019 | 108 | 0.160 |
Why?
| | Protein Interaction Maps | 1 | 2018 | 35 | 0.150 |
Why?
| | Lipids | 1 | 2022 | 564 | 0.150 |
Why?
| | PPAR delta | 1 | 2018 | 6 | 0.150 |
Why?
| | Tetrahydrofolates | 1 | 2018 | 11 | 0.150 |
Why?
| | Oxidative Phosphorylation | 1 | 2019 | 154 | 0.150 |
Why?
| | Piperidines | 1 | 2019 | 159 | 0.150 |
Why?
| | Blood Platelets | 1 | 2020 | 326 | 0.150 |
Why?
| | Rats, Sprague-Dawley | 3 | 2007 | 2182 | 0.150 |
Why?
| | Exosomes | 1 | 2018 | 92 | 0.140 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2017 | 26 | 0.140 |
Why?
| | alpha-Linolenic Acid | 1 | 2017 | 7 | 0.140 |
Why?
| | Protein Processing, Post-Translational | 3 | 2015 | 399 | 0.140 |
Why?
| | Glyburide | 1 | 2017 | 35 | 0.140 |
Why?
| | Prospective Studies | 2 | 2021 | 6195 | 0.140 |
Why?
| | Mice, Inbred ICR | 1 | 2017 | 108 | 0.140 |
Why?
| | Phosphoproteins | 2 | 2011 | 293 | 0.140 |
Why?
| | Arachidonic Acid | 1 | 2017 | 112 | 0.140 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2017 | 9 | 0.140 |
Why?
| | Muscle Contraction | 1 | 2019 | 388 | 0.140 |
Why?
| | Proteomics | 1 | 2022 | 815 | 0.140 |
Why?
| | Receptors, Calcitriol | 1 | 2016 | 53 | 0.130 |
Why?
| | Electroacupuncture | 1 | 2016 | 2 | 0.130 |
Why?
| | Pediatric Obesity | 1 | 2023 | 489 | 0.130 |
Why?
| | Cholecalciferol | 1 | 2016 | 47 | 0.130 |
Why?
| | Resource Allocation | 1 | 2016 | 37 | 0.130 |
Why?
| | Echocardiography | 1 | 2019 | 569 | 0.130 |
Why?
| | Coenzyme A Ligases | 1 | 2016 | 11 | 0.130 |
Why?
| | Diet | 3 | 2022 | 1080 | 0.130 |
Why?
| | Amino Acid Transport System y+L | 1 | 2015 | 4 | 0.130 |
Why?
| | Caspase 3 | 2 | 2014 | 234 | 0.130 |
Why?
| | Fatty Acid Binding Protein 3 | 1 | 2015 | 4 | 0.130 |
Why?
| | Androgens | 1 | 2017 | 167 | 0.130 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2017 | 210 | 0.130 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2015 | 12 | 0.130 |
Why?
| | Excitatory Amino Acids | 1 | 2015 | 7 | 0.130 |
Why?
| | Transport Vesicles | 1 | 2015 | 18 | 0.130 |
Why?
| | Dietary Sucrose | 1 | 2015 | 45 | 0.120 |
Why?
| | Anti-Inflammatory Agents | 1 | 2019 | 445 | 0.120 |
Why?
| | Child | 4 | 2023 | 18401 | 0.120 |
Why?
| | Lipase | 1 | 2015 | 55 | 0.120 |
Why?
| | Autophagy | 1 | 2017 | 235 | 0.120 |
Why?
| | Hepatocytes | 2 | 2014 | 195 | 0.120 |
Why?
| | Heart | 1 | 2019 | 613 | 0.120 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2015 | 133 | 0.120 |
Why?
| | Ovarian Neoplasms | 1 | 2019 | 386 | 0.120 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 2087 | 0.120 |
Why?
| | Interleukin-1beta | 2 | 2014 | 368 | 0.120 |
Why?
| | Myocardium | 1 | 2019 | 911 | 0.110 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2017 | 285 | 0.110 |
Why?
| | Analysis of Variance | 2 | 2017 | 1218 | 0.110 |
Why?
| | bcl-2-Associated X Protein | 1 | 2013 | 45 | 0.110 |
Why?
| | Liver Neoplasms | 1 | 2017 | 504 | 0.110 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2384 | 0.110 |
Why?
| | Mitochondria | 1 | 2019 | 744 | 0.110 |
Why?
| | Transfection | 1 | 2015 | 863 | 0.110 |
Why?
| | Ceramides | 1 | 2014 | 91 | 0.110 |
Why?
| | Receptor, IGF Type 1 | 3 | 2021 | 58 | 0.110 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2013 | 32 | 0.110 |
Why?
| | Energy Metabolism | 2 | 2015 | 727 | 0.110 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1468 | 0.110 |
Why?
| | Apoptosis | 2 | 2019 | 2349 | 0.100 |
Why?
| | Blood Urea Nitrogen | 1 | 2012 | 51 | 0.100 |
Why?
| | Protein Subunits | 1 | 2013 | 200 | 0.100 |
Why?
| | Oxygen | 1 | 2017 | 851 | 0.100 |
Why?
| | MicroRNAs | 1 | 2018 | 600 | 0.100 |
Why?
| | Hyperandrogenism | 1 | 2012 | 14 | 0.100 |
Why?
| | Brain | 1 | 2023 | 2355 | 0.100 |
Why?
| | Prognosis | 1 | 2019 | 3315 | 0.090 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2011 | 21 | 0.090 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2012 | 150 | 0.090 |
Why?
| | Phosphatidylcholines | 2 | 2023 | 132 | 0.090 |
Why?
| | Colorado | 1 | 2020 | 4090 | 0.090 |
Why?
| | Mothers | 1 | 2015 | 650 | 0.080 |
Why?
| | Stromal Cells | 2 | 2021 | 96 | 0.080 |
Why?
| | Inflammation | 2 | 2022 | 2464 | 0.080 |
Why?
| | Glucocorticoids | 1 | 2013 | 526 | 0.080 |
Why?
| | Immunity, Innate | 1 | 2014 | 720 | 0.080 |
Why?
| | Sex Factors | 1 | 2013 | 1706 | 0.080 |
Why?
| | Microscopy, Fluorescence | 2 | 2021 | 393 | 0.080 |
Why?
| | Pregnancy Trimester, Third | 1 | 2008 | 79 | 0.070 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenases | 1 | 2007 | 3 | 0.070 |
Why?
| | Sex Characteristics | 2 | 2023 | 636 | 0.070 |
Why?
| | Oxidative Stress | 2 | 2018 | 1068 | 0.070 |
Why?
| | Amino Acid Transport System y+ | 1 | 2007 | 4 | 0.070 |
Why?
| | Glucose Transporter Type 3 | 1 | 2007 | 11 | 0.070 |
Why?
| | Hyperlipoproteinemia Type I | 1 | 2007 | 7 | 0.070 |
Why?
| | Uterus | 2 | 2019 | 191 | 0.070 |
Why?
| | Fluorescent Antibody Technique | 2 | 2018 | 396 | 0.070 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2018 | 160 | 0.070 |
Why?
| | Lipoprotein Lipase | 1 | 2007 | 54 | 0.070 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2006 | 20 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2013 | 2764 | 0.070 |
Why?
| | Glucose Clamp Technique | 1 | 2007 | 181 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 4402 | 0.070 |
Why?
| | Interviews as Topic | 1 | 2008 | 575 | 0.060 |
Why?
| | Mass Spectrometry | 2 | 2021 | 622 | 0.060 |
Why?
| | Lactic Acid | 1 | 2006 | 272 | 0.060 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2017 | 141 | 0.060 |
Why?
| | Osmolar Concentration | 1 | 2004 | 169 | 0.060 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2004 | 192 | 0.060 |
Why?
| | Dietary Supplements | 2 | 2018 | 459 | 0.060 |
Why?
| | Microscopy, Electron | 1 | 2004 | 408 | 0.060 |
Why?
| | Ether | 1 | 2023 | 7 | 0.060 |
Why?
| | Ethyl Ethers | 1 | 2023 | 4 | 0.060 |
Why?
| | Plasmalogens | 1 | 2023 | 6 | 0.060 |
Why?
| | Ethers | 1 | 2023 | 16 | 0.060 |
Why?
| | Electrolytes | 1 | 2003 | 55 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2023 | 66 | 0.050 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2014 | 145 | 0.050 |
Why?
| | Cell Cycle Proteins | 1 | 2007 | 549 | 0.050 |
Why?
| | Adipose Tissue | 1 | 2007 | 545 | 0.050 |
Why?
| | Body Composition | 1 | 2007 | 590 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 1836 | 0.050 |
Why?
| | Pregnancy, High-Risk | 1 | 2002 | 12 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2006 | 673 | 0.050 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 33 | 0.050 |
Why?
| | MAP Kinase Signaling System | 2 | 2014 | 271 | 0.050 |
Why?
| | Pregnant Women | 1 | 2023 | 129 | 0.050 |
Why?
| | Insulin Receptor Substrate Proteins | 2 | 2013 | 56 | 0.050 |
Why?
| | Maleimides | 1 | 2021 | 23 | 0.050 |
Why?
| | Cell Shape | 1 | 2021 | 54 | 0.050 |
Why?
| | Receptors, Erythropoietin | 1 | 2021 | 22 | 0.050 |
Why?
| | Norway | 1 | 2021 | 36 | 0.050 |
Why?
| | Epithelial Cells | 1 | 2007 | 946 | 0.050 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2021 | 151 | 0.050 |
Why?
| | Cholesterol | 1 | 2023 | 368 | 0.050 |
Why?
| | Esterification | 1 | 2020 | 12 | 0.050 |
Why?
| | Parity | 1 | 2021 | 97 | 0.050 |
Why?
| | Erythropoietin | 1 | 2021 | 72 | 0.050 |
Why?
| | Reference Values | 1 | 2002 | 739 | 0.040 |
Why?
| | Receptors, Amino Acid | 1 | 2020 | 25 | 0.040 |
Why?
| | NF-kappa B | 2 | 2014 | 636 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 787 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 250 | 0.040 |
Why?
| | Adolescent | 3 | 2019 | 17800 | 0.040 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2019 | 25 | 0.040 |
Why?
| | Indoles | 1 | 2021 | 300 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2020 | 152 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2019 | 84 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 184 | 0.040 |
Why?
| | Arachidonic Acids | 1 | 2018 | 56 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 157 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2021 | 496 | 0.040 |
Why?
| | Neoplasm Grading | 1 | 2019 | 241 | 0.040 |
Why?
| | Mitosis | 1 | 2019 | 164 | 0.040 |
Why?
| | Perilipin-2 | 1 | 2018 | 36 | 0.040 |
Why?
| | Phagosomes | 1 | 2017 | 38 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 917 | 0.040 |
Why?
| | Sheep | 1 | 2020 | 761 | 0.040 |
Why?
| | Lysosomes | 1 | 2017 | 123 | 0.030 |
Why?
| | Lipogenesis | 1 | 2017 | 56 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1422 | 0.030 |
Why?
| | Phosphoserine | 1 | 2015 | 33 | 0.030 |
Why?
| | Blotting, Western | 2 | 2010 | 1143 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2015 | 139 | 0.030 |
Why?
| | Corticosterone | 1 | 2016 | 211 | 0.030 |
Why?
| | Adenylate Kinase | 1 | 2014 | 26 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 863 | 0.030 |
Why?
| | Caspase 10 | 1 | 2014 | 5 | 0.030 |
Why?
| | Time Factors | 1 | 2004 | 6077 | 0.030 |
Why?
| | Chorionic Gonadotropin | 1 | 2014 | 78 | 0.030 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2014 | 99 | 0.030 |
Why?
| | Transcription Factors | 1 | 2021 | 1526 | 0.030 |
Why?
| | GRB2 Adaptor Protein | 1 | 2013 | 12 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2014 | 89 | 0.030 |
Why?
| | Incidence | 1 | 2019 | 2314 | 0.030 |
Why?
| | Transgenes | 1 | 2014 | 170 | 0.030 |
Why?
| | Estradiol Dehydrogenases | 1 | 2012 | 1 | 0.030 |
Why?
| | Estrous Cycle | 1 | 2012 | 14 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 2700 | 0.030 |
Why?
| | Binding Sites | 1 | 2015 | 1166 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2013 | 167 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2019 | 2173 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 1981 | 0.020 |
Why?
| | Random Allocation | 1 | 2012 | 328 | 0.020 |
Why?
| | Receptors, Androgen | 1 | 2012 | 131 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2783 | 0.020 |
Why?
| | Dexamethasone | 1 | 2013 | 316 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 285 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2012 | 371 | 0.020 |
Why?
| | Blood Pressure | 1 | 2016 | 1531 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1014 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 26605 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1417 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 990 | 0.020 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2007 | 27 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 36 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 1824 | 0.020 |
Why?
| | Amniotic Fluid | 1 | 2006 | 64 | 0.020 |
Why?
| | Permeability | 1 | 2006 | 149 | 0.020 |
Why?
| | Protons | 1 | 2006 | 73 | 0.020 |
Why?
| | Ultrasonography, Prenatal | 1 | 2006 | 237 | 0.010 |
Why?
| | Muscle Proteins | 1 | 2006 | 210 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 2784 | 0.010 |
Why?
|
|
Jansson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|